Resumen
Introduction: Multidrug resistant (MDR) organism infections in pediatric oncology patients have become a frequent cause of morbidity and mortality. The main objective of the following study was to determine the incidence and risk factors associated to MDR organisms infections in a sample of patients from UNOP. Methods: Retrospective study. The inclusion criteria were documented MDR infection with positive culture (blood, urinary, tissue or endotracheal aspirate). We reviewed medical records between January 1st, 2015 to December 31st, 2015; obtaining the medical records of 30 patients who fulfilled the inclusion criteria. Results: Sixty percent (60%) of patients female; 70% had the diagnosis of hematologic malignancy; 37% of patients were diagnosed with clinical sepsis and the incidence of sepsis was 3.49%.
Citas
Infection with multidrug-resistant gram-negative bacteria in a pediatric oncology intensive care unit: risk factors and outcomes.de Oliveira Costa P, Atta EH, da Silva AR. J Pediatric (Rio J). 2015 Sep-Oct; 91(5):435- 41. doi: 10.1016/j.jped.2014.11.009. Epub 2015 Jun 6
Miedema K, van de Wetering M. Empirical antibiotic therapy for febrile neutropenia in pediatric cancer patients. The Cochrane Library 2012, Issue 3
El-Mahallawy H, El-Wakil, Moneer M, and Shalaby L. Antibiotic Resistance Is Associated With Longer Bacteremic Episodes and Worse Outcome in Febrile Neutropenic Children With Cancer. Pediatric Blood Cancer 2011; 57:283–288
Antimicrobial resistance: global report on surveillance. 1. Anti-infective agents - classification. 2. Anti-infective agents - adverse effects. 3. Drug resistance, microbial - drug effects. 4. Risk management. 5. Humans. I. World Health Organization. ISBN 978 92 4 156474 8 (NLM classification: QV 250
National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992-April 2000, issued June 2000. Am J Infect Control. 2000 Dec; 28(6):429-48
A comprehensive approach to the prevention of central venous catheter complications: results of 10-year prospective surveillance in pediatric hematology-oncology patients. Cesaro S, Cavaliere M, Pegoraro A, Gamba P, Zadra N, Tridello G.Ann Hematol. 2016 Apr; 95(5):817-25. doi: 10.1007/s00277-016-2634-x. Epub 2016 Mar 10. PMID:26961934
Central venous catheter-related complications in children with oncological/hematological diseases: an observational study of 418 devices. Fratino G, Molinari AC, Parodi S, Longo S, Saracco P, Castagnola E, Haupt R.Ann Oncol. 2005 Apr; 16(4):648-54. Epub 2005 Jan 27. PMID:15677621
Copyright
License
Copyright (c) 2017 Patricia Sandoval
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who publish in this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License 4.0 (CC BY-NC_SA 4.0) that indicates: a) It is allowed that others share the work, with an acknowledgement of the work's authorship and initial publication in this journal, b) The work may not be used for commercial purposes, c) If it's remixed, transformed, or built upon the material, one must distribute the contributions under the same license as the original
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository, website or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
